Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,203 | 11,106 | 45,778 | 80,386 | 48,902 |
| Marketable Securities | 126,101 | 94,871 | 87,367 | 79,666 | 138,395 |
| Receivables | 56,841 | 5,580 | 4,390 | 5,924 | 2,913 |
| Inventories | 4,476 | 4,277 | 4,606 | 4,680 | 4,755 |
| TOTAL | $363,594 | $122,459 | $146,827 | $173,324 | $198,360 |
| Non-Current Assets | |||||
| PPE Net | 14,540 | 15,007 | 15,475 | 15,865 | 16,299 |
| Intangibles | 64,700 | 93,779 | 94,221 | 94,662 | 95,104 |
| Other Non-Current Assets | 1,754 | 1,898 | 1,993 | 285 | 429 |
| TOTAL | $80,994 | $110,684 | $111,689 | $110,812 | $111,832 |
| Total Assets | $444,588 | $233,143 | $258,516 | $284,136 | $310,192 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,289 | 1,115 | 1,115 | 1,115 | 1,115 |
| Accounts payable and accrued liabilities | 20,907 | 10,028 | 13,874 | 12,052 | 51,480 |
| Accrued Expenses | 11,511 | 9,083 | 10,800 | 21,245 | 13,794 |
| TOTAL | $44,824 | $22,469 | $28,221 | $36,751 | $68,506 |
| Non-Current Liabilities | |||||
| Long Term Debt | 233,837 | 243,953 | 243,912 | 243,887 | 243,830 |
| Deferred Revenues | 1,117 | 2,243 | 2,432 | 2,339 | 2,117 |
| Other Non-Current Liabilities | 1,215 | 1,325 | 1,433 | 238 | 252 |
| TOTAL | $235,052 | $275,560 | $275,982 | $273,790 | $271,087 |
| Total Liabilities | $279,876 | $298,029 | $304,203 | $310,541 | $339,593 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,272 | 106,272 | 106,272 | 106,272 | 105,925 |
| Common Shares | 106 | 106 | 106 | 106 | 106 |
| Retained earnings | -1,290,306 | -1,516,392 | -1,493,374 | -1,471,577 | -1,471,485 |
| Other shareholders' equity | 219 | 269 | 216 | 112 | 53 |
| TOTAL | $164,712 | $-64,886 | $-45,687 | $-26,405 | $-29,401 |
| Total Liabilities And Equity | $444,588 | $233,143 | $258,516 | $284,136 | $310,192 |